KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $94,000 | +1.1% | 13,226 | +3.0% | 0.00% | 0.0% |
Q2 2017 | $93,000 | +22.4% | 12,844 | +3.8% | 0.00% | 0.0% |
Q1 2017 | $76,000 | +13.4% | 12,372 | +8.9% | 0.00% | 0.0% |
Q4 2016 | $67,000 | +15.5% | 11,362 | +3.7% | 0.00% | – |
Q3 2016 | $58,000 | +52.6% | 10,959 | +2.8% | 0.00% | – |
Q3 2015 | $38,000 | -71.6% | 10,664 | +1.2% | 0.00% | -100.0% |
Q1 2015 | $134,000 | -41.0% | 10,539 | -34.4% | 0.00% | -33.3% |
Q4 2014 | $227,000 | +16.4% | 16,074 | +13.2% | 0.00% | 0.0% |
Q3 2014 | $195,000 | -3.5% | 14,196 | +8.2% | 0.00% | 0.0% |
Q2 2014 | $202,000 | – | 13,125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |